Drug intelligence / Profile preview

nalbuphine + magnesium sulfate

Development stage
Approved
Modality
DNA Intercalators/Alkylators → Nucleic Acid-Directed Small Molecules → Small Molecules
Administration
Intrathecal
01

Overview

Nalbuphine + magnesium sulfate is a combination of two agents commonly used as adjuvants in anesthesia and pain management, particularly in perioperative and obstetric settings. Nalbuphine is a synthetic opioid analgesic with mixed agonist-antagonist activity—acting as an agonist at kappa opioid receptors and an antagonist at mu opioid receptors—providing potent analgesia with a ceiling effect on respiratory depression. Magnesium sulfate, an inorganic salt, acts primarily as an NMDA receptor antagonist and has been shown to enhance the efficacy of other analgesics while providing additional benefits such as reducing shivering during spinal anesthesia. The combination is studied for its ability to improve postoperative pain control, prolong the duration of anesthesia, reduce perioperative shivering, and potentially decrease the need for additional opioids[1][6][8].

02

Targets

DOR (Opioid Receptor Delta 1)KOR (Kappa opioid receptor)MOR (Mu opioid receptor)NMDAR (Glutamate receptor ionotropic, NMDA)

Beyond the preview

Go deeper on nalbuphine + magnesium sulfate.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on nalbuphine + magnesium sulfate.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call